SEC Form D · filed July 3, 2017
Alitair Pharmaceuticals, Inc
Offering
$5.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MORRISTOWN, NJ
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (8)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗